Induction of apoptosis in ovarian cancer cells by miR-493-3p directly targeting AKT2, STK38L, HMGA2, ETS1 and E2F5
- 144 Downloads
Apoptosis is a form of directed programmed cell death with a tightly regulated signalling cascade for the destruction of single cells. MicroRNAs (miRNAs) play an important role as fine tuners in the regulation of apoptotic processes. MiR-493-3p mimic transfection leads to the induction of apoptosis causing the breakdown of mitochondrial membrane potential and the activation of Caspases resulting in the fragmentation of DNA in several ovarian carcinoma cell lines. Ovarian cancer shows with its pronounced heterogeneity a very high death-to-incidence ratio. A target gene analysis for miR-493-3p was performed for the investigation of underlying molecular mechanisms involved in apoptosis signalling pathways. Elevated miR-493-3p levels downregulated the mRNA and protein expression levels of Serine/Threonine Kinase 38 Like (STK38L), High Mobility Group AT-Hook 2 (HMGA2) and AKT Serine/Threonine Kinase 2 (AKT2) by direct binding as demonstrated by luciferase reporter assays. Notably, the protein expression of RAF1 Proto-Oncogene, Serine/Threonine Kinase (RAF1) was almost completely downregulated by miR-493-3p. This interaction, however, was indirect and regulated by STK38L phosphorylation. In addition, RAF1 transcription was diminished as a result of reduced transcription of ETS proto-oncogene 1 (ETS1), another direct target of miR-493-3p. Taken together, our observations have uncovered the apoptosis inducing potential of miR-493-3p through its regulation of multiple target genes participating in the extrinsic and intrinsic apoptosis pathway.
KeywordsMicroRNA Cancer Signalling pathways Targets RAF1
This study was funded by the Postgraduate Scholarships Act of the Ministry for Science, Research and Arts of the Federal State Government of Baden-Wuerttemberg, Germany. Further acknowledgements address the International Graduate School in Molecular Medicine of Ulm University, Germany, for scientific encouragement and support to Michael Kleemann. Pamela Fischer-Posovszky receives funding from the Baden-Württemberg Stiftung, Germany. The results published here are based on data generated by the TCGA Research Network. In addition, the authors are grateful to Dr. Anne-Marie Mes-Masson (Centre Hospitalier de l´Université de Montréal, Canada) for providing us with the TOV21G and TOV112D cells as well as to Alex Shu-Wing Ng (Department of Obstetrics, Gynecology and Reproductive Biology, the Brigham and Women’s Hospital, Boston, USA) for the HOSE 2170 cells. The OVCAR3, A2780 and A2780-cis cells were kindly provided by Verena Jendrossek (Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Germany).
Compliance with ethical standards
The authors declare that the experiments comply with the current laws of the Federal Republic of Germany.
Conflict of interest
The authors declare that they have no conflict of interest.
- 13.Pal MK, Jaiswar SP, Dwivedi VN, Tripathi AK, Dwivedi A, Sankhwar P (2015) MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer. Cancer Biol Med 12(4):328–341. https://doi.org/10.7497/j.issn.2095-3941.2015.0024 CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Kleemann M, Bereuther J, Fischer S, Marquart K, Hanle S, Unger K, Jendrossek V, Riedel CU, Handrick R, Otte K (2016) Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis. Oncotarget. https://doi.org/10.18632/oncotarget.13095 CrossRefPubMedCentralGoogle Scholar
- 21.Ueno K, Hirata H, Majid S, Yamamura S, Shahryari V, Tabatabai ZL, Hinoda Y, Dahiya R (2012) Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by down-regulating RhoC and FZD4. Mol Cancer Ther 11(1):244–253. https://doi.org/10.1158/1535-7163.MCT-11-0592 CrossRefPubMedGoogle Scholar
- 25.Choi P-W, Yang J, Ng S-K, Feltmate C, Muto MG, Hasselblatt K, Lafferty-Whyte K, JeBailey L, MacConaill L, Welch WR, Fong W-P, Berkowitz RS, Ng S-W (2016) Loss of E-cadherin disrupts ovarian epithelial inclusion cyst formation and collective cell movement in ovarian cancer cells. Oncotarget 7(4):4110–4121. https://doi.org/10.18632/oncotarget.6588 CrossRefPubMedGoogle Scholar
- 27.Samouelian V, Maugard CM, Jolicoeur M, Bertrand R, Arcand SL, Tonin PN, Provencher DM, Mes-Masson AM (2004) Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A. Cancer Chemother Pharmacol 54(6):497–504. https://doi.org/10.1007/s00280-004-0843-9 CrossRefPubMedGoogle Scholar
- 28.Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young RC, Ozols RF (1987) Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 47(2):414–418PubMedGoogle Scholar
- 35.Fischer S, Buck T, Wagner A, Ehrhart C, Giancaterino J, Mang S, Schad M, Mathias S, Aschrafi A, Handrick R, Otte K (2014) A functional high-content miRNA screen identifies miR-30 family to boost recombinant protein production in CHO cells. Biotechnol J 9(10):1279–1292. https://doi.org/10.1002/biot.201400306 CrossRefPubMedGoogle Scholar
- 37.Lassmann S, Weis R, Makowiec F, Roth J, Danciu M, Hopt U, Werner M (2007) Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med (Berlin, Germany) 85(3):293–304. https://doi.org/10.1007/s00109-006-0126-5 CrossRefGoogle Scholar
- 38.Zhang SX, Garcia-Gras E, Wycuff DR, Marriot SJ, Kadeer N, Yu W, Olson EN, Garry DJ, Parmacek MS, Schwartz RJ (2005) Identification of direct serum-response factor gene targets during Me2SO-induced P19 cardiac cell differentiation. J Biol Chem 280(19):19115–19126. https://doi.org/10.1074/jbc.M413793200 CrossRefPubMedGoogle Scholar
- 39.Iorns E, Turner NC, Elliott R, Syed N, Garrone O, Gasco M, Tutt AN, Crook T, Lord CJ, Ashworth A (2008) Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer. Cancer Cell 13(2):91–104. https://doi.org/10.1016/j.ccr.2008.01.001 CrossRefPubMedGoogle Scholar
- 40.Jain P, Fierst TM, Han HJ, Smith TE, Vakil A, Storm PB, Resnick AC, Waanders AJ (2017) CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles. Oncogene 36(45):6348–6358. https://doi.org/10.1038/onc.2017.276 CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Noble C, Mercer K, Hussain J, Carragher L, Giblett S, Hayward R, Patterson C, Marais R, Pritchard CA (2008) CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation. Mol Cell 31(6):862–872. https://doi.org/10.1016/j.molcel.2008.08.026 CrossRefPubMedPubMedCentralGoogle Scholar
- 44.Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O’Briant K, Godwin AK, Urban N, Drescher CW, Knudsen BS, Tewari M (2009) Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One 4(4):e5311. https://doi.org/10.1371/journal.pone.0005311 CrossRefPubMedPubMedCentralGoogle Scholar
- 53.Yu H, Lim Hong H, Tjokro Natalia O, Sathiyanathan P, Natarajan S, Chew Tian W, Klonisch T, Goodman Steven D, Surana U, Dröge P (2014) Chaperoning HMGA2 protein protects stalled replication forks in stem and cancer cells. Cell Rep 6(4):684–697. https://doi.org/10.1016/j.celrep.2014.01.014 CrossRefPubMedGoogle Scholar
- 56.Grant TJ, Mehta AK, Gupta A, Sharif AAD, Arora KS, Deshpande V, Ting DT, Bardeesy N, Ganem NJ, Hergovich A, Singh A (2017) STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines. Oncotarget 8(45):78556–78572. https://doi.org/10.18632/oncotarget.20833 CrossRefPubMedPubMedCentralGoogle Scholar
- 59.Fischer S, Wagner A, Kos A, Aschrafi A, Handrick R, Hannemann J, Otte K (2013) Breaking limitations of complex culture media: functional non-viral miRNA delivery into pharmaceutical production cell lines. J Biotechnol 168(4):589–600. https://doi.org/10.1016/j.jbiotec.2013.08.027 CrossRefPubMedGoogle Scholar
- 61.Rudner J, Ruiner CE, Handrick R, Eibl HJ, Belka C, Jendrossek V (2010) The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation. Radiat Oncol 5:108. https://doi.org/10.1186/1748-717X-5-108 CrossRefPubMedPubMedCentralGoogle Scholar
- 63.Emmerling VV, Fischer S, Stiefel F, Holzmann K, Handrick R, Hesse F, Horer M, Kochanek S, Otte K (2016) Temperature-sensitive miR-483 is a conserved regulator of recombinant protein and viral vector production in mammalian cells. Biotechnol Bioeng 113(4):830–841. https://doi.org/10.1002/bit.25853 CrossRefPubMedGoogle Scholar
- 64.Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126(6):1203–1217. https://doi.org/10.1016/j.cell.2006.07.031 CrossRefPubMedPubMedCentralGoogle Scholar
- 65.Vlachos IS, Paraskevopoulou MD, Karagkouni D, Georgakilas G, Vergoulis T, Kanellos I, Anastasopoulos IL, Maniou S, Karathanou K, Kalfakakou D, Fevgas A, Dalamagas T, Hatzigeorgiou AG (2015) DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucleic Acids Res 43(Database issue):D153–D159. https://doi.org/10.1093/nar/gku1215 CrossRefPubMedGoogle Scholar
- 69.Chou CH, Chang NW, Shrestha S, Hsu SD, Lin YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, Tsai TR, Ho SY, Jian TY, Wu HY, Chen PR, Lin NC, Huang HT, Yang TL, Pai CY, Tai CS, Chen WL, Huang CY, Liu CC, Weng SL, Liao KW, Hsu WL, Huang HD (2016) miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res 44(D1):D239–D247. https://doi.org/10.1093/nar/gkv1258 CrossRefPubMedGoogle Scholar
- 70.R Development Core Team (2011) R: A Language and Environment for Statistical Computing. Vienna, Austria: the R Foundation for Statistical Computing. ISBN:3-900051-07-0. Available online at http://www.R-project.org/